2026-10-23 08:20 UTC
HR10887
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
📢 Introduced in House
https://congress.gov/bill/119th-congress/house-bill/10887
#HR10887 #congress119 #house #democrat #congress #newbill
Replies (0)
No replies.